Cartilage oligomeric matrix protein (COMP): A biomarker of arthritis

Susan Tseng, A Hari Reddi, Paul E. Di Cesare

Research output: Contribution to journalArticlepeer-review

111 Scopus citations


Arthritis is a chronic disease with a significant impact on the population. It damages the cartilage, synovium, and bone of the joints causing pain, impairment, and disability in patients. Current methods for diagnosis of and monitoring the disease are only able to detect clinical manifestations of arthritis late in the process. However, with the recent onset of successful treatments for rheumatoid arthritis and osteoarthritis, it becomes important to identify prognostic factors that can predict the evolution of arthritis. This is especially critical in the early phases of disease so that these treatments can be started as soon as possible to slow down progression of the disease. A valuable approach to monitor arthritis would be by measuring biological markers of cartilage degradation and repair to refl ect variations in joint remodeling. One such potential biological marker of arthritis is cartilage oligomeric matrix protein (COMP). In various studies, COMP has shown promise as a diagnostic and prognostic indicator and as a marker of the disease severity and the effect of treatment. This review highlights the progress in the utilization of COMP as a biomarker of arthritis.

Original languageEnglish (US)
Pages (from-to)33-44
Number of pages12
JournalBiomarker Insights
Issue number4
StatePublished - 2009


  • Arthritis
  • Biomarker
  • Cartilage oligomeric matrix protein

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Biochemistry, medical


Dive into the research topics of 'Cartilage oligomeric matrix protein (COMP): A biomarker of arthritis'. Together they form a unique fingerprint.

Cite this